TE
MIRM icon

Tema ETFs’s Mirum Pharmaceuticals MIRM Stock Holding History

Tema ETFs’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,957
Closed -$657K – 590
2025
Q3 		$657K Sell
8,957
-990
-10% -$62.9K 0.05% 332
2025
Q2 		$506K Sell
9,947
-1,485
-13% -$66.1K 0.13% 137
2025
Q1 		$515K Sell
11,432
-30,536
-73% -$1.44M 0.15% 109
2024
Q4 		$1.74M Buy
+41,968
New +$1.75M 0.72% 41

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Tema ETFs's MIRM Position: Q4 2025 in Review

Tema ETFs sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 8,957 shares — an estimated $657K sold.

Tema ETFs first reported a position in MIRM in Q4 2024 and held it in 4 quarters. The position peaked at $1.74M in Q4 2024. 282 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Tema ETFs reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Tema ETFs sold 8,957 Mirum Pharmaceuticals shares in Q4 2025, an estimated $657K.
  • Tema ETFs first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Tema ETFs's Mirum Pharmaceuticals position peaked at $1.74M in Q4 2024.
  • 282 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Tema ETFs's 13F filing for Q4 2025, filed 16 Jan 2026.